Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | HSD17B3 | P37058 | 7/20 | 0.63 |
| ▸ | KDM4E | B2RXH2 | 5/20 | 0.63 |
| ▸ | ALDH1A1 | P00352 | 4/20 | 0.63 |
| ▸ | GAA | P10253 | 4/20 | 0.63 |
| ▸ | CA12 | O43570 | 4/20 | 0.63 |
| ▸ | CA9 | Q16790 | 4/20 | 0.63 |
| ▸ | AKR1B1 | P15121 | 3/20 | 0.63 |
| ▸ | GLA | P06280 | 3/20 | 0.63 |
| ▸ | MAOB | P27338 | 2/20 | 0.63 |
| ▸ | LMNA | P02545 | 1/20 | 0.63 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.63 |
| ▸ | CYP2C9 | P11712 | 1/20 | 0.63 |
| ▸ | HPGD | P15428 | 1/20 | 0.63 |
| ▸ | UGT1A1 | P22309 | 1/20 | 0.63 |
| ▸ | CASP1 | P29466 | 1/20 | 0.63 |
| ▸ | KDR | P35968 | 1/20 | 0.63 |
| ▸ | CASP7 | P55210 | 1/20 | 0.63 |
| ▸ | MCL1 | Q07820 | 1/20 | 0.63 |
| ▸ | HSD17B10 | Q99714 | 1/20 | 0.63 |
| ▸ | KMT2A | Q03164 | 2/20 | 0.62 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL15842416 | 0.83 | CA9 (0.50) | HSD17B3KDM4EALDH1A1GAACA12 | |
| SCHEMBL20876143 | 0.82 | KDM4E (0.61) | HSD17B3KDM4EALDH1A1GAACA12 | |
| SCHEMBL13232055 | 0.81 | HSD17B3 (0.61) | HSD17B3KDM4EALDH1A1GAACA12 | |
| SCHEMBL25134930 | 0.80 | KDM4E (0.61) | HSD17B3KDM4EALDH1A1GAACA12 | |
| SCHEMBL6031059 | 0.80 | CA12 (0.78) | KDM4EALDH1A1GAACA12CA9 | |
| SCHEMBL3217325 | 0.80 | ALDH1A1 (0.47) | HSD17B3KDM4EALDH1A1GAACA12 | |
| SCHEMBL14329544 | 0.79 | CA9 (0.58) | KDM4EALDH1A1CA12CA9MAOB | |
| SCHEMBL2812687 | 0.79 | AKR1B1 (0.64) | HSD17B3KDM4EALDH1A1GAACA12 | |
| Hymecromone SCHEMBL7594956 | 0.79 | KDM4E (0.87) | HSD17B3KDM4EALDH1A1GAACA12 | |
| Hymecromone SCHEMBL29364837 | 0.77 | HSD17B3 (1.00) | HSD17B3KDM4EALDH1A1GAACA12 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 11 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20070123469-A1 | N- or C- terminally modified small peptides | ZEALAND PHARMA A/S (DK) | 2007-05-31 | — | — | US | claimed |
| CN-113717187-B | Fluorescent probe for revealing endoplasmic reticulum repair mechanism by using fluorescence lifetime imaging, and preparation method and application thereof | 安徽大学 | 2022-06-17 | — | — | CN | disclosed |
| EP-2813891-B1 | Photoresist underlayer film-forming composition and pattern forming process | SHINETSU CHEMICAL CO (JP) | 2018-01-17 | — | — | EP | disclosed |
| US-9620363-B2 | Underlayer film-forming composition and pattern forming process | SHIN-ETSU CHEMICAL CO., LTD. (JP) | 2017-04-11 | — | — | US | disclosed |
| US-9620363-B2 | Underlayer film-forming composition and pattern forming process | SHIN-ETSU CHEMICAL CO., LTD. (JP) | 2017-04-11 | — | — | US | disclosed |
| EP-2813891-A2 | Photoresist underlayer film-forming composition and pattern forming process | Shin-Etsu Chemical Co., Ltd. (JP) | 2014-12-17 | — | — | EP | disclosed |
| US-20140363956-A1 | UNDERLAYER FILM-FORMING COMPOSITION AND PATTERN FORMING PROCESS | SHIN-ETSU CHEMICAL CO., LTD. (JP) | 2014-12-11 | — | — | US | disclosed |
| US-20140363956-A1 | UNDERLAYER FILM-FORMING COMPOSITION AND PATTERN FORMING PROCESS | SHIN-ETSU CHEMICAL CO., LTD. (JP) | 2014-12-11 | — | — | US | disclosed |
| US-7749969-B2 | N- or C- terminally modified small peptides | ZEALAND PHARMA A/S (DK) | 2010-07-06 | — | — | US | disclosed |
| US-20070123469-A1 | N- or C- terminally modified small peptides | ZEALAND PHARMA A/S (DK) | 2007-05-31 | — | — | US | disclosed |
| WO-2007007060-A2 | N- OR C- TERMINALLY MODIFIED SMALL PEPTIDES | ZEALAND PHARMA A/S (DK) | 2007-01-18 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20070123469-A1 | N- or C- terminally modified small peptides | PTMS, CYP11A1, CYP3A4 | HSD17B3 604/4885KDM4E 2661/4885ALDH1A1 1790/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.